Literature DB >> 21999118

BDNF/TrkB signaling as an anti-tumor target.

Rafael Roesler, Caroline Brunetto de Farias, Ana Lucia Abujamra, Algemir Lunardi Brunetto, Gilberto Schwartsmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21999118     DOI： 10.1586/era.11.150

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  12 in total

1.  (R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors.

Authors:  Ha-Soon Choi; Paul V Rucker; Zhicheng Wang; Yi Fan; Pamela Albaugh; Greg Chopiuk; Francois Gessier; Fangxian Sun; Francisco Adrian; Guoxun Liu; Tami Hood; Nanxin Li; Yong Jia; Jianwei Che; Susan McCormack; Allen Li; Jie Li; Auzon Steffy; AnneMarie Culazzo; Celine Tompkins; Van Phung; Andreas Kreusch; Min Lu; Bin Hu; Apurva Chaudhary; Mahavir Prashad; Tove Tuntland; Bo Liu; Jennifer Harris; H Martin Seidel; Jon Loren; Valentina Molteni
Journal:  ACS Med Chem Lett       Date:  2015-03-16       Impact factor: 4.345

2.  Targeting tyrosine receptor kinase B in gliomas.

Authors:  Kelly V Pinheiro; Camila Alves; Marienela Buendia; Mirela S Gil; Amanda Thomaz; Gilberto Schwartsmann; Caroline Brunetto de Farias; Rafael Roesler; Robert L Bowman; Qianghu Wang; Angel Carro; Roel G W Verhaak; Massimo Squatrito
Journal:  Neuro Oncol       Date:  2016-09-14       Impact factor: 12.300

3.  Subacute toxic effects of silver nanoparticles oral administration and withdrawal on the structure and function of adult Albino Rats' hepatic tissue.

Authors:  Shimaa Mohammad Yousof; Horeya Erfan; Marwa Mohamed Hosny; Shaimaa A Shehata; Karima El-Sayed
Journal:  Saudi J Biol Sci       Date:  2022-03-11       Impact factor: 4.052

4.  Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.

Authors:  Kelly V Pinheiro; Amanda Thomaz; Bárbara Kunzler Souza; Victoria Anne Metcalfe; Natália Hogetop Freire; André Tesainer Brunetto; Caroline Brunetto de Farias; Mariane Jaeger; Victorio Bambini; Christopher G S Smith; Lisa Shaw; Rafael Roesler
Journal:  Mol Biol Rep       Date:  2020-08-29       Impact factor: 2.316

5.  Influence of GRPR and BDNF/TrkB signaling on the viability of breast and gynecologic cancer cells.

Authors:  Daniela B Cornelio; Caroline B DE Farias; Débora S Prusch; Tiago E Heinen; Rafael P Dos Santos; Ana L Abujamra; Gilberto Schwartsmann; Rafael Roesler
Journal:  Mol Clin Oncol       Date:  2012-08-07

6.  Diverse distribution of tyrosine receptor kinase B isoforms in rat multiple tissues.

Authors:  Kosuke Otani; Muneyoshi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2017-07-29       Impact factor: 1.267

7.  Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer.

Authors:  Clément Mazouffre; Sophie Geyl; Aurélie Perraud; Sabrina Blondy; Marie-Odile Jauberteau; Muriel Mathonnet; Mireille Verdier
Journal:  J Cell Mol Med       Date:  2017-06-09       Impact factor: 5.310

8.  Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.

Authors:  Wei Bao; Haifeng Qiu; Tingting Yang; Xin Luo; Huijuan Zhang; Xiaoping Wan
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

9.  Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.

Authors:  Tiago Elias Heinen; Rafael Pereira Dos Santos; Amanda da Rocha; Michel Pinheiro Dos Santos; Patrícia Luciana da Costa Lopez; Marco Aurélio Silva Filho; Bárbara Kunzler Souza; Luís Fernando da Rosa Rivero; Ricardo Gehrke Becker; Lauro José Gregianin; Algemir Lunardi Brunetto; André Tesainer Brunetto; Caroline Brunetto de Farias; Rafael Roesler
Journal:  Oncotarget       Date:  2016-06-07

10.  Licochalcone A Inhibits BDNF and TrkB Gene Expression and Hypoxic Growth of Human Tumor Cell Lines.

Authors:  Michitsune Arita; Junichi Koike; Nobuji Yoshikawa; Motonari Kondo; Hiromichi Hemmi
Journal:  Int J Mol Sci       Date:  2020-01-13       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.